Autosomal Dominant Dopa-responsive Dystonia

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Autosomal dominant dopa-responsive dystonia (DYT5a) is a rare neurometabolic disorder characterized by childhood-onset dystonia that shows a dramatic and sustained response to low doses of levodopa (L-dopa) and that may be associated with parkinsonism at an older age.

Genes related to Autosomal Dominant Dopa-responsive Dystonia

GCH1

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Autosomal Dominant Dopa-responsive Dystonia

Intellectual disability
Hearing impairment
Scoliosis
Ataxia
Hypertension
Fatigue
Talipes equinovarus
Depressivity
Babinski sign
Pes cavus

And another 24 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Autosomal Dominant Dopa-responsive Dystonia Is also known as hpd with marked diurnal fluctuation, gtpch1-deficient dopa-responsive dystonia, gtpch1-deficient drd, dyt5a, hereditary progressive dystonia with marked diurnal fluctuation, autosomal dominant segawa syndrome.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Autosomal Dominant Dopa-responsive Dystonia Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Complete Dopa-Responsive Dystonia (DYT5) Evaluation. By Athena Diagnostics Inc (United States). TH, GCH1 Specificity 50 % Genes 100 %
GCH1 DNA Deletion Analysis (DYT5). By Athena Diagnostics Inc (United States). GCH1 Specificity 100 % Genes 100 %
GCH1 DNA Sequencing Test. By Athena Diagnostics Inc (United States). GCH1 Specificity 100 % Genes 100 %
Dystonia. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SPR, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX , (...) View the complete list with 57 more genes Panel complete gene list SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SPR, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX, SLC19A3, TPK1, TREM2, ARX, RNASEH2A, VPS13A, L2HGDH, THAP1, FA2H, PDHX, ADAR, CP, RNASEH2C, CHMP2B, MMADHC, C19orf12, RNASEH2B, DCAF17, CYP27A1, FOXRED1, DDC, WDR45, DLAT, FASTKD2, EARS2, ATP13A2, DRD2, DRD5, PRRT2, SLC46A1, TOR1A, AFG3L2, SDHAF1, ERCC6, FOXG1, GAMT, GCDH, GCH1, MR1, HPRT1, AP1S2, KCNQ2, MAT1A, ARSA, MPV17, ATM, ATP1A2, ATP1A3, PRKN, ATP7B, AUH, PLP1, PNKD, PSEN1, PTEN, PTS, QDPR Specificity 2 % Genes 100 %
Epilepsy/Seizure. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SLC2A1, SLC6A8, SLC9A6, BTD, SPTAN1, CDKL5, STXBP1, SYN1, TSC1, TSC2, UBE3A, CNTNAP2, CACNA1A, CACNB4, ARHGEF9 , (...) View the complete list with 78 more genes Panel complete gene list SCN1A, SCN1B, SCN2A, SCN8A, SCN9A, SLC2A1, SLC6A8, SLC9A6, BTD, SPTAN1, CDKL5, STXBP1, SYN1, TSC1, TSC2, UBE3A, CNTNAP2, CACNA1A, CACNB4, ARHGEF9, ZEB2, CASK, CASR, PLCB1, DNAJC5, SLC19A3, EFHC1, LIAS, SCARB2, PRICKLE1, CPA6, ADGRV1, ARX, MAGI2, ASPM, CHRNA2, CHRNA4, CHRNB2, SLC25A22, PRICKLE2, MBD5, TPP1, CLN3, CLN5, CLN6, CLN8, NHLRC1, KCTD7, ABAT, WDR62, MMACHC, CSTB, CTSD, DCX, TSEN54, MFSD8, WDR45, ADSL, TBC1D24, PNPO, PRRT2, EPM2A, FLNA, FOLR1, FOXG1, GABRA1, ALDH5A1, GABRG2, GAMT, GATM, GCH1, GLDC, GOSR2, ADGRG1, GRIN2A, AMT, KCNJ10, KCNMA1, KCNQ2, KCNQ3, LGI1, MCPH1, MECP2, MEF2C, MTHFR, ATP1A2, NRXN1, OPHN1, PAFAH1B1, PCBD1, ALDH7A1, PHGDH, PNKP, POLG, PPT1, PSPH, PTS, QDPR Specificity 2 % Genes 100 %
Infantile Epilepsy. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC6A8, SLC9A6, BTD, SPTAN1, CDKL5, STXBP1, TCF4, TSC1, TSC2, UBE3A, CNTNAP2, ZEB2, LIAS, ARX, MAGI2 , (...) View the complete list with 40 more genes Panel complete gene list SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC6A8, SLC9A6, BTD, SPTAN1, CDKL5, STXBP1, TCF4, TSC1, TSC2, UBE3A, CNTNAP2, ZEB2, LIAS, ARX, MAGI2, SLC25A22, MBD5, TPP1, CLN3, CLN5, CLN6, CLN8, KCTD7, MMACHC, CTSD, MFSD8, WDR45, ADSL, TBC1D24, PNPO, PRRT2, FOLR1, FOXG1, ALDH5A1, GABRG2, GAMT, GCH1, GLDC, GRIN2A, AMT, KCNJ10, KCNQ2, KCNQ3, MECP2, MEF2C, MTHFR, NRXN1, PCBD1, ALDH7A1, PHGDH, PNKP, POLG, PPT1, PTS, QDPR Specificity 2 % Genes 100 %
Movement Disorders Panel. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1 , (...) View the complete list with 72 more genes Panel complete gene list SCP2, SGCE, SLC20A2, SLC2A1, SLC6A3, SNCA, SPR, SQSTM1, SUCLA2, SUOX, TAF1, TH, TIMM8A, TREX1, MCOLN1, VPS35, FBXO7, CACNA1A, NPC2, PINK1, PANK2, SAMHD1, APTX, SLC19A3, PARK7, TRIM32, TPK1, TREM2, ARX, RNASEH2A, LRRK2, VPS13A, L2HGDH, THAP1, FA2H, PDHX, ADAR, CP, RNASEH2C, CSF1R, CHMP2B, MMADHC, C19orf12, RNASEH2B, DCAF17, CYP27A1, FOXRED1, DCTN1, DDC, WDR45, DLAT, FASTKD2, EARS2, ATP13A2, DRD2, DRD5, PRRT2, SLC46A1, TOR1A, AFG3L2, SDHAF1, ERCC6, FOXG1, FTL, FUCA1, GAMT, GBA, GCDH, GCH1, MR1, HPRT1, AP1S2, KCNQ2, MAPT, MAT1A, ARSA, MPV17, ATM, ATP1A2, ATP1A3, PRKN, ATP7B, KIF1A, AUH, PLA2G6, PLP1, PNKD, POLG, PSEN1, PTEN, PTS, QDPR Specificity 2 % Genes 100 %
Parkinson's Disease. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). SLC6A3, SNCA, TAF1, TH, VPS35, FBXO7, PINK1, PARK7, LRRK2, CSF1R, DCTN1, ATP13A2, GBA, GCH1, MAPT, ATP1A3, PRKN, PLA2G6, POLG Specificity 6 % Genes 100 %

You can get up to 93 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

ORPHANET Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1 PILAROWSKI-BJORNSSON SYNDROME; PILBOS MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11 INFANTILE SYSTEMIC HYALINOSIS